Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • UqDiamantina
    Junior Member
    • Apr 2014
    • 3

    #1

    Principal Research Fellow role

    Principal Research Fellow

    Job no:496072
    Area:UQ Diamantina Institute
    Salary (FTE):Academic Research Level D ($123,757.86 - $136,343.73)
    Work type:Full Time - Fixed Term
    Location: Brisbane

    The University of Queensland Diamantina Institute was established in 2007 as the sixth research institute of The University of Queensland. The aim of the Institute is to develop a better understanding of the molecular and cellular basis of disease, and to translate that understanding into practical outcomes for patients. Based at the Translational Research Institute (TRI) at the Princess Alexandra Hospital teaching campus in Brisbane, the Institute has almost 270 researchers and students who work closely with clinicians in the areas of cancer, immunology and genomic medicine. UQDI is the largest partner in TRI, and is building major programs in Immunology, Cancer and Genomic Medicine research, with a particular focus on research aimed at development of new treatments. Details of the research interests of academic staff may be accessed on the Institute's web site at http://www.di.uq.edu.au/research.

    The role

    The successful appointee will develop and lead an internationally competitive research group focused on cancer genetics. The researcher will be expected to engage and lead collaborative research with other members of UQDI in the cancer and genomics programmes, the Faculty/School, TRI and PA hospital campus in general to ensure maximum opportunities for research outcome translation to the clinic. They will be required to supervise and mentor post-doctoral fellows, doctoral, masters and honours students.

    The person

    Applicants should possess a PhD in bioinformatics, genetics, biology, a relevant area of computer science or applied mathematics. The successful applicant will have substantial experience in the generation and analysis of next generation sequencing data from cancerous tissues, and will be an expert in bioinformatics, applied statistics or both. Experience in the analysis of blood or skin cancers would be an advantage but is not essential. Applicants must also demonstrate the ability to lead and collaborate in multi-discipline projects, and possess strong communication and time management skills.

    Remuneration

    This is a full-time, fixed term appointment for 5 years at Academic level D. The remuneration package will be in the range of $123,757 - $136,343 p.a., plus employer superannuation contributions of up to 17% (total package will be in the range of $144,796- $159,522 p.a.)

    Enquiries

    To discuss this role please contact Professor David Evans on +61 7 3443 7051 or at [email protected].

    To submit an application for this role please go to http://jobs.uq.edu.au/caw/en/job/496...esearch-fellow
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...